VSee Health, Inc. (NASDAQ:VSEE – Get Free Report) was the target of a large decline in short interest in the month of April. As of April 30th, there was short interest totaling 472,222 shares, a decline of 39.7% from the April 15th total of 783,682 shares. Based on an average daily trading volume, of 663,120 shares, the short-interest ratio is currently 0.7 days.
VSee Health Price Performance
VSee Health stock traded down $0.00 during midday trading on Friday, reaching $0.18. 486,126 shares of the stock traded hands. The company has a current ratio of 0.51, a quick ratio of 0.51 and a debt-to-equity ratio of 0.11. The firm has a fifty day moving average price of $0.23 and a two-hundred day moving average price of $0.42. VSee Health has a fifty-two week low of $0.17 and a fifty-two week high of $2.52.
VSee Health (NASDAQ:VSEE – Get Free Report) last posted its earnings results on Tuesday, March 31st. The company reported ($0.31) earnings per share (EPS) for the quarter. The business had revenue of $3.93 million for the quarter.
Institutional Inflows and Outflows
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of VSee Health in a report on Monday, April 20th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company currently has a consensus rating of “Sell”.
Get Our Latest Research Report on VSee Health
About VSee Health
VSee Health is a telehealth technology company that develops secure, HIPAA-compliant software solutions for virtual care. The company’s flagship platform offers high-definition video visits, real-time messaging and collaboration tools designed to streamline remote consultations between patients and healthcare providers. VSee’s solutions are built to integrate with electronic health record systems and include features such as digital waiting rooms, screen sharing and file transfer capabilities.
In addition to video conferencing, VSee Health provides remote patient monitoring (RPM) tools that enable clinicians to collect biometric data, such as blood pressure, heart rate and glucose readings, from patients in their homes.
See Also
- Five stocks we like better than VSee Health
- Robinhood, SoFi, and Webull Are Telling Very Different Stories
- As Broadcom Eclipses $2 Trillion, Private Credit Giants Wants In
- Target the Red-Hot Spin-Off and Merger Space With These ETFs
- Samsung Joins the $1 Trillion Club as AI Memory Demand Explodes
Receive News & Ratings for VSee Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VSee Health and related companies with MarketBeat.com's FREE daily email newsletter.
